Scribe highlights latest data on Lp(a)-lowering therapy and novel AI platform for next-generation CRISPR-based therapeutics at two premier conferences ...

An international multidisciplinary team has demonstrated for the first time that CRISPR-based gene activation (CRISPRa) can ...

In this article, we will be taking a look at the 11 Best Performing Biotech Stocks So Far in 2025. CRISPR Therapeutics AG ...

Researchers engineered and screened dozens of base editors to precisely target a single mutation without editing other portions of the DNA.

Gene-edited pancreatic cells have been transplanted into a patient with type 1 diabetes for the first time. They produced ...

-Preliminary data demonstrate that CTX112™ has the potential to provide meaningful clinical benefit with a well-tolerated safety profile using a standard lymphodepletion protocol- -Company announced ...

CRISPR Therapeutics reports promising Phase 1 clinical data for CTX310™, with significant triglyceride and LDL reductions, and updates on other programs. CRISPR Therapeutics announced promising new ...

Health Secretary Robert F. Kennedy picked Prasad to be FDA vaccine regulator. Prasad's social media reveals criticism of Verve's 1st-gen PCSK9 approach, which may signal negative sentiment for CRISPR ...

Every era of biology has been defined by a tool: the microscope, the sequencer, CRISPR. Artificial intelligence is emerging ...

Incredible new data presented recently at the European Hematology Association Congress has revealed an experimental CRISPR gene editing therapy is both safe and effective up to three years after ...